Crossmark

A Comprehensive Analysis of Biopharmaceutical Products Listed in the FDA’s Purple Book

Crossref DOI link: https://doi.org/10.1208/s12249-024-02802-0

Published Online: 2024-04-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Fuduan

Zhong, Hao

Chan, Ging

Ouyang, Defang https://orcid.org/0000-0002-8052-4773
License Information

Text and Data Mining valid from 2024-04-18

Version of Record valid from 2024-04-18
More Information

Article History

Received: 26 December 2023

Accepted: 1 April 2024

First Online: 18 April 2024

Declarations

:

: The authors declare no competing interests.